Conjugated linoleic acid (CLA): is it time to supplement asthma therapy?

Pulm Pharmacol Ther. 2011 Oct;24(5):540-8. doi: 10.1016/j.pupt.2011.03.005. Epub 2011 Apr 21.

Abstract

The limitations and side effects of existing asthma therapies prompt interest in complementary and alternative therapies. Conjugated linoleic acids (CLA) are a family of natural fatty acids found primarily in beef and dairy products. These molecules have a variety of biological properties which suggest potential benefit in asthma, including effects on energy regulation, lipid metabolism, inflammation and immune function. Here we review the evidence for these effects from pre-clinical and clinical studies, their significance in the context of human asthma, and discuss the potential role for CLA supplementation in asthma management.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Asthmatic Agents / adverse effects
  • Anti-Asthmatic Agents / therapeutic use*
  • Asthma / drug therapy*
  • Asthma / physiopathology
  • Clinical Trials as Topic
  • Dietary Supplements
  • Drug Evaluation, Preclinical
  • Humans
  • Linoleic Acids, Conjugated / administration & dosage*
  • Linoleic Acids, Conjugated / pharmacology

Substances

  • Anti-Asthmatic Agents
  • Linoleic Acids, Conjugated